September 2024

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it expects to release its audited results for the financial year ended 30 June 2024 during the last week of September 2024.   Dr Peter Sargent (CEO) and Dr Jim Millen (Non-Executive Chairman) will provide a live presentation relating to...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has been awarded a new contract by an existing, large pharma client. The project involves updating two models previously created for the client with newly generated clinical data. These models are based on the Company’s proprietary Virtual...

Read More

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it is attending BioForward 2024, OBN’s  'Roadmap for Growth' Life Sciences event, in Oxford on 24th of September 2024. The event attended by leaders of R&D companies across all therapeutic areas aims to create connections within industry that...

Read More